Pierre Fabre Medicament

Pierre Fabre S.a.

P. F. Medicament

Andre Delhon

Henri Cousse

Gilbert Mouzin

Jean-Pierre Rieu

Jean-Francois Patoiseau

Jean-Marie Autin

Philippe Oms

Didier Junquero

Guy Pitet

Jean-Francedillaois Patoiseau

2,3,5-trimethyl-4-hydroxyanilide derivatives, preparation thereof and

Glycylanilide derivatives, their preparation and their application in

The invention relates to new derivatives of biphenyl primary alcohols, their preparation and use as medicaments useful in the treatment and prevention of atherosclerotic disorders. The new derivatives have the general formula ##STR1## in which X represents a halogen atom, and more particularly chlorine, bromine or fluorine in ortho or meta position,

Lipid- and cholesterol-reducing derivatives of halo-biphenyl primary

The invention concerns halo-biphenyl tertiary alcohols of the general formula: ##STR1## in which: X is chlorine or bromine in ortho or meta position.

Halo-biphenyl tertiary alcohols useful in therapy in the treatment of

The invention relates to compounds of the formula ##STR1## in which R and R' are identical or different and may be a hydrogen, an alkyl, a dialkylamino, an alkoxy, a halogen, or a hydroxy. These compounds are useful as drugs in the control of thromboses.

Antithrombotic 2-prenyl-3-oxo-5,6-diaryl-as-triazenes

This invention relates to new chemical compounds useful as drugs, as well as to pharmaceutical compositions containing the same. This application claims their hypocholesterolemic use. The new products are aromatic keto acid compounds with antiinflammatory as well as analgetic and hypocholesteremic acitvity and having the general formula: ##STR1## wherein R.sub.1 is hydrogen, halogen, phenyl, halophenyl, alkyl, phenoxy, or substituted phenoxy.

Method of reducing cholesterol using certain aromatic keto acids

Growing community of inventors

Castres, France

Andre Delhon